SCHEMBL25464094

SCHEMBL25464094

CC(C)(C(=O)NC1CCC1)c1cc(F)cc(C(N)=O)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FAAH O00519 5/20 0.39
▸ GRM5 P41594 4/20 0.39
▸ PDK1 Q15118 1/20 0.38
▸ PDK2 Q15119 1/20 0.38
▸ PDK3 Q15120 1/20 0.38
▸ PDK4 Q16654 1/20 0.38
▸ NPC1 O15118 2/20 0.37
▸ RAB9A P51151 2/20 0.37
▸ HTT P42858 1/20 0.36
▸ EPHX2 P34913 2/20 0.33
▸ MLLT1 Q03111 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ TRPA1 O75762 1/20 0.33
▸ FAAH2 Q6GMR7 1/20 0.33
▸ MGLL Q99685 1/20 0.33
▸ HDAC6 Q9UBN7 1/20 0.33
▸ TAS1R3 Q7RTX0 1/20 0.33
▸ TAS1R1 Q7RTX1 1/20 0.33
▸ TAS1R2 Q8TE23 1/20 0.33
▸ EPHX1 P07099 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25464125 0.88 GRM5 (0.39) GRM5PDK1PDK2PDK3PDK4
SCHEMBL25464147 0.88 PDK1 (0.44) GRM5PDK1PDK2PDK3PDK4
SCHEMBL25464119 0.83 TAS1R3 (0.41) GRM5PDK1PDK2PDK3PDK4
SCHEMBL25460797 0.79 PARP1 (0.39) EPHX2
SCHEMBL25464763 0.79 CACNA1B (0.38) PDK1PDK2PDK3PDK4EPHX2
SCHEMBL25464042 0.79 NPC1 (0.39) GRM5PDK1PDK2PDK3PDK4
SCHEMBL25464079 0.77 GRM5 (0.50) GRM5NPC1RAB9AHTTEPHX2
SCHEMBL25464778 0.77 CNR1 (0.36) PDK1PDK2PDK3PDK4GAA
SCHEMBL25464788 0.77 TACR1 (0.42) PDK1PDK2PDK3PDK4GAA
SCHEMBL25464785 0.74 MEN1 (0.42) EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230151074-A1 MODULATORS OF G-PROTEIN COUPLED RECEPTORS CARMOT THERAPEUTICS, INC. 2023-05-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230151074-A1 MODULATORS OF G-PROTEIN COUPLED RECEPTORS GIPR, GLP1R, GCGR FAAH 1551/4885GRM5 78/4885PDK1 1840/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback